Cologne, Germany

Simone Brückner



Average Co-Inventor Count = 12.3

ph-index = 1

Forward Citations = 15(Granted Patents)


Location History:

  • Köln, DE (2013)
  • Cologne, DE (2017 - 2018)

Company Filing History:


Years Active: 2013-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: Innovator Spotlight: Simone Brückner and His Impact on Biomedicine

Introduction: Simone Brückner is a notable inventor based in Cologne, Germany, recognized for his significant contributions to the field of biomedicine. With a remarkable portfolio of three patents, Brückner has made strides in the development of innovative therapies targeting critical pathways in human health.

Latest Patents: Brückner's recent patents showcase advances in the production of monoclonal antibodies. His work on "Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)" involves isolated monoclonal antibodies that effectively bind to human tissue factor pathway inhibitor (TFPI). These inventions include isolated nucleic acid molecules encoding such antibodies and pharmaceutical compositions aimed at treating coagulation deficiencies. Additionally, he has developed methods for producing these antibodies. Another significant patent concerns "Antibodies to TNFα," providing antibodies, antigen-binding portions, and derivatives capable of binding to tumor necrosis factor alpha (TNFα), along with the corresponding nucleic acids and vectors.

Career Highlights: Brückner has had an impressive career, demonstrating his expertise in biopharmaceutical innovation. He has worked with Bayer Pharma AG and Bayer Intellectual Property GmbH, two prominent companies in the life sciences and pharmaceutical sectors. His experience in these organizations has allowed him to refine his skills and advance his research in antibody development.

Collaborations: Throughout his career, Brückner has collaborated with esteemed colleagues such as Christian Votsmeier and Susanne Steinig. Working alongside these talented professionals has contributed to enriching his research and innovation efforts within the biotechnology arena.

Conclusion: Simone Brückner stands as a testament to the power of innovation in medicine. His patented inventions, particularly in monoclonal antibody technology, promise to enhance therapeutic applications and improve patient outcomes. As Brückner continues his work, he remains an influential figure in the landscape of biomedical engineering, inspiring future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…